Radient Pharmaceuticals has selected Irvine-based TS Pharma to market and sell Onko-Sure in Central American and Caribbean nations including.

TS Pharma will market the product in Antigua, Aruba, Bahamas, Barbados, Belize, Bermuda, Cayman Islands, Costa Rica, Curacao, Netherland Antilles, Dominican Republic, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Panama, and Trinidad & Tobago.

Onko-Sure is a simple, non-invasive blood test used for the detection and/or monitoring of 15 different types of cancers.

Radient chairman and CEO Douglas MacLellan said with this agreement, they are making Onko-Sure available in additional new markets.